alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 60, Number 53 (Monday, March 20, 1995)]
[Notices]
[Page 14737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-6718]



-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE
Department of the Navy


Government Owned Inventions; Availability for Licensing

AGENCY: Department of the Navy.

ACTION: Notice of availability of inventions for licensing.

-----------------------------------------------------------------------

SUMMARY: The inventions listed below are assigned to the United States 
Government as represented by the Secretary of the Navy and are 
available for licensing by the Department of the Navy.

    Request for copies of the patent applications cited should be 
directed to the Office of Naval Research, ONR 00CC, Ballston Tower One, 
800 North Quincy Street, Arlington, Virginia 22217-5660 and must 
include the application serial number.


FOR FURTHER INFORMATION CONTACT: Mr. R.J. Erickson, Staff Patent 
Attorney, Office of Naval Research, ONR 00CC, Balston Tower One, 800 
North Quincy Street, Arlington, Virginia 22217-5660, telephone (703) 
696-4001.
    Patent Application Serial No. 08/287,027: Fiber-Optic Rotary Joint 
with Bundle Collimator Assemblies; filed August 8, 1994;
    Patent Application Serial No. 08/287,029: A Fiber-Optic Bundle and 
Collimator Assembly; filed August 8, 1994; and
    Patent Application Serial No. 08/287,028: Method For Making Fiber-
Optic Bundle Collimator Assembly; filed August 8, 1994.

    Dated: March 14, 1995.
M.D. Schetsle,
LT, JAGC, USNR, Alternate Federal Register Liaison Officer.
[FR Doc. 95-6718 Filed 3-17-95; 8:45 am]
BILLING CODE 3810-AE-M
Exhibit
32.1





Certification
of Periodic Report


Pursuant
to 18 U.S.C. Section 1350


As
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





Pursuant to, and for purposes only of,
18 U.S.C. § 1350, the undersigned hereby certifies that (i) the Quarterly Report
of Peoples Bancorp, Inc. on Form 10-Q for the quarter ended June 30, 2009, as
filed with the Securities and Exchange Commission (the “Report”), fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934, and (ii) information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of Peoples
Bancorp, Inc. and Subsidiaries.





Date:  August
      13, 2009
              /s/ Thomas G. StevensonThomas
      G. StevensonPresident/Chief
      Executive Officer&
      Chief Financial Officer
EXHIBIT 10.2 

                                                                                                                    

GOLDEN SPIRIT ENTERPRISES LTD.

(the “Company”)

CONSENT TO ACT AS DIRECTOR

I hereby consent to act as a director of the Company and acknowledge that I am not disqualified to become or to act as a director under Section 141 of the Delaware General Corporation Law.

I hereby confirm that:

1.

I am not under the age of 18 years;

2.

I have not been found by a court, in the United States of America or elsewhere, to be incapable of managing my own affairs;

3.

I am not an undischarged bankrupt; and

4.

I have not been convicted in or out of Delaware of an offence in connection with the promotion, formation or management of a corporation or unincorporated business, or of an offence involving fraud.

In addition, the undersigned hereby consents to the holding of any meeting of the directors or of a committee of the directors of the Company by means of such telephonic, electronic or other communication facility, as permit all persons participating in the subject meetings to communicate adequately with each other.




This consent shall continue in effect from year to year so long as the undersigned is re-elected to the board of directors, provided that in the event that the undersigned revokes this consent or resigns from the board of directors, this consent shall cease to have effect from the date of receipt in writing by the Company of such revocation or resignation, as the case may be, or, if the latter, the effective date of such resignation.

DIRECTORS HAVE SUBSTANTIAL DUTIES AND OBLIGATIONS AND MAY BE SUBJECT TO SIGNIFICANT LIABILITIES. THE PERSON SIGNING THIS CONSENT SHOULD OBTAIN INDEPENDENT LEGAL ADVICE.

		
	Dated:

	June 24, 2011


	Print name:

	Sharon Deutsch 


	Address:

	 

35 South Ocean Avenue

Patchogue, New York

11772


	Signature

	/s/:  Sharon Deutsch
EXHIBIT 32

Securities
and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549



In
connection with the Annual Report of Eastern American Natural Gas Trust (the "Trust") on Form 10-K for the year ended December 31, 2011, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, not in its individual capacity but solely as the trustee of the Trust, certifies pursuant to 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to its knowledge:



The
above certification is furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350) and is not being filed as part of the Form 10-K or as a
separate disclosure document.

The Bank of New York Mellon Trust Company,
N.A.,Trustee, Trustee for Eastern American Natural
Gas TrustBy:

/s/ MIKE ULRICH Vice PresidentThe Bank of New York Mellon Trust
Company, N.A.


Date:
March 9, 2012

---



QuickLinks
**Exhibit 32.1**

**CERTIFICATION      PURSUANT TO**

**18      U.S.C. §1350,**

**AS      ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

|   | 1.     | The                Report fully complies with the requirements of Section 13(a) or 15(d)                of the Securities Exchange Act of 1934; and                                          |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                              |
|   | 2.     | The                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |

|   |                                                                             |                                   |
|--------|----------------------------------------------------------------------------------|----------------------------------------|
|   |                                                                             | /s/                W. Bruce Comer |
|   | W.                Bruce Comer                                                    |
|   | Chief                Executive OfficerJune                7,                2007 |

----
EXHIBIT 23.1


                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference to (a) the Registration
Statement on Form S-3 (333-97341), as amended, and the Prospectus contained
therein, (b) the Registration Statement on Form S-3 (333-49528), as amended, and
the Prospectus contained therein, (c) the Registration Statement on Form S-3
(333-1044), as amended, and the Prospectus contained therein, (d) the
Registration Statement on Form S-3 (033-55792-NY), as amended, and the
Prospectus contained therein, (e) the Registration Statement on Form S-8
(333-01048), as amended, and the Prospectus contained therein, (f) the
Registration Statement on Form S-3 (333-69311), as amended, and the Prospectus
contained therein, (g) the Registration Statement on Form S-3 (333-30054) and
the Prospectus contained therein, (h) the Registration Statement on Form S-3
(333-32642) and the Prospectus contained therein, (i) the Registration Statement
on Form S-8 (333-31832) and the Prospectus contained therein, and (j) the
Registration Statement on Form S-3 (333-69134) and the Prospectus contained
therein, of our report dated September 16, 2002, relating to the financial
statements which appear in this Form 10-K of Greg Manning Auctions, Inc.





/s/  Amper, Politziner & Mattia P.C.

Edison, New Jersey
September 25, 2002
II 

Calendar No. 14 

117TH CONGRESS 

1ST SESSION S. 400 

To designate the headquarters building of the Department of Transportation 

located at 1200 New Jersey Avenue, SE, in Washington, DC, as the 

‘‘William T. Coleman, Jr., Federal Building’’. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 24, 2021 

Mr. WICKER (for himself, Ms. CANTWELL, Mr. CARPER, Mrs. CAPITO, Mr. 

SCOTT of South Carolina, Mr. BOOKER, Mr. WARNOCK, Mr. CASEY, Mr. 

TOOMEY, Mr. SULLIVAN, Mr. INHOFE, Mr. BARRASSO, and Ms. 

DUCKWORTH) introduced the following bill; which was read twice and referred to the Committee on Environment and Public Works 

MARCH 24, 2021 

Reported by Mr. CARPER, without amendment 

A BILL 

To designate the headquarters building of the Department 

of Transportation located at 1200 New Jersey Avenue, 

SE, in Washington, DC, as the ‘‘William T. Coleman, 

Jr., Federal Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•S 400 RS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘William T. Coleman, 

3 Jr., Department of Transportation Headquarters Act’’. 

4 SEC. 2. WILLIAM T. COLEMAN, JR., FEDERAL BUILDING. 

5 (a) IN GENERAL.—The headquarters building of the 

6 Department of Transportation located at 1200 New Jer7 sey Avenue, SE, in Washington, DC, shall be known and 

8 designated as the ‘‘William T. Coleman, Jr., Federal 

9 Building’’. 

10 (b) REFERENCES.—Any reference in a law, map, reg11 ulation, document, paper, or other record of the United 

12 States to the building referred to in subsection (a) shall 

13 be deemed to be a reference to the ‘‘William T. Coleman, 

14 Jr., Federal Building’’. 


pamtmann on DSKBC07HB2PROD with BILLS

pamtmann on DSKBC07HB2PROD with BILLS
Calendar No. 14 

117TH CONGRESS 

1ST SESSION S. 400 

A BILL 

To designate the headquarters building of the De-

‘‘William T. Coleman, Jr., Federal Building’’. Jersey Avenue, SE, in Washington, DC, as the partment of Transportation located at 1200 New 

MARCH 24, 2021 

Reported without amendment 


pamtmann on DSKBC07HB2PROD with BILLS
[Federal Register Volume 60, Number 52 (Friday, March 17, 1995)]
[Sunshine Act Meetings]
[Page 14485]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-6830]



-----------------------------------------------------------------------


United States Institute of Peace

DATE/TIME: Thursday, March 23, 1995, 9:00 a.m.-5:30 p.m.

LOCATION: 1550 M Street NW., Washington, DC 20005, First Floor (Lobby) 
Conference Room.

STATUS: (Open Session)--Portions may be closed pursuant to Subsection 
(c) of Section 552(b) of Title 5, United States Code, as provided in 
subsection 1706(h)(3) of the United States Institute of Peace Act, 
Public Law 98-525.

AGENDA: Approval of Minutes of the Sixty-ninth Meeting of the Board of 
Directors; Chairman's Report; President's Report; General issues; 
Selection of Solicited Grants; Selection of 1995-1996 Fellows for 
Jennings Randolph Fellowship Program.

CONTACT: Mr. Wilson Grabill, Public Affairs Specialist, Public Affairs 
and Information Office, Telephone: (202) 457-1700.

    Dated: March 13, 1995.
Charles E. Nelson,
Vice President, United States Institute of Peace.
[FR Doc. 95-6830 Filed 3-15-95; 3:02 pm]
BILLING CODE 3155-01-M
Exhibit
      32.2





Ener1,
      Inc.


500
      West
      Cypress Creek Road, Suite 100


Ft.
      Lauderdale, Florida, 33309




March
      11,
      2008





Securities
      and Exchange Commission


100
      F
      Street, NE


Washington,
      DC 20549





Re:
      Certification of Principal Financial Officer Pursuant To 18 U.S.C. Sec.
      1350





Dear
      Ladies and Gentlemen:





In
      connection with the accompanying annual report on Form 10-KSB of Ener1, Inc.,
      for the year ended December 31, 2007 as filed with the Securities and Exchange
      Commission, I, Gerard Herlihy, Chief Financial Officer of Ener1, Inc., hereby
      certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
      906
      of the Sarbanes-Oxley Act of 2002, that:





1)
            such
                annual report on Form 10-KSB of Ener1, Inc., for the year ended December
                31, 2007 fully complies with the requirements of Section 13(a) or
                15(d) of
                the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));
                and





2)
            the
                information contained in such annual report on Form 10-KSB of Ener1,
                Inc.,
                for the year ended December 31, 2007, fairly presents, in all material
                respects, the financial condition and results of operations of Ener1,
                Inc.





/s/
                Gerard HerlihyGerard
                Herlihy
              Chief
                Financial Officer
              (Duly
                Authorized Principal Financial and Accounting Officer and Duly Authorized
                Officer)




A
      signed
      original of this written statement required by Section 906, or other
      document authenticating, acknowledging or otherwise adopting the signature
      that
      appears in typed form within the electronic version of this written statement
      required by Section 906, has been provided to Ener1, Inc. and will be
      retained by Ener1, Inc. and furnished to the Securities and Exchange Commission
      or its staff upon request.





This
      certification is being “furnished” as Exhibit 32.2 to Ener1, Inc.’s annual
      report and shall not be deemed “filed” for purposes of Section 18 of the
      Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the
      liabilities of that section, nor shall it be deemed incorporated by reference
      in
      any filing under the Securities Act of 1933 or the Exchange Act, except as
      expressly set forth by specific reference in such a filing.
----

| 1. | I have reviewed this Amendment to the Annual Report on Form 10-K/A of Abaxis, Inc. and |
|----|----------------------------------------------------------------------------------------|

| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date: July 30, 2018 | /s/ Ross Taylor                                       |
|---------------------|-------------------------------------------------------|
|                | Ross Taylor                                           |
|                | Chief Financial Officer and Vice President of Finance |

----
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 4, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3990

II-VI Incorporated:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request concerns a product strategically important or related to 

“Made in China 2025” or other Chinese industrial programs.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

March 15, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3848

Academy, Ltd:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

* * * * * * * * * * * * * * * * * * * * *

LEON KLEMPNER , *

* No. 16

- 1197 V Petitioner, * Special Master Christian J. Moran

*

v. * Filed: December 13

, 2017

*

SECRETARY OF HEALTH * Stipulation; Influenza (“flu”) vaccine; AND HUMAN SERVICES, * Guillain

- Barré syndrome (“GBS”) ; * peripheral neuropathy.

* Respondent. *

* * * * * * * * * * * * * * * * * * * * *

Robert J. Krakow , Law Office of Robert J. Krakow, P.C., New York, NY, for Petitioner;

Ilene C. Albala

, United States Dep’t of Justice, Washington, DC, for Respondent.

UNPUBLISHED DECISION 1

On December 12, 2017 , the parties filed a joint stipulation concerning the petition for compensation filed by Leon Klempner on September 26, 2016

. P etitioner alleged that the influenza (“flu”) vaccine he received on June 27, 2013

, which is contained in the Vaccine Injury Table (the “Table”), 42 C .F.R. §100.3(a),

caused him to suffer Guillain

- Barré syndrome and peripheral neuropathy

. P etitioner further alleged that he suffered the residual effects of this injury for more than six months. Petitioner represents that there has been no prior award or

settl ement of a civil action for damages on his behalf as a result of his condition.

1 T he E -Government Act, 44 U.S.C. § 3501 note (2012) (Federal Management and

Promotion of Electronic Government Services) , requires that the Court post this decision on its website. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special master will appear in the document posted on the website.2 Respondent denies that the flu vaccine either caused or significantly aggravated petitioner ’ s alleged injuries or any other injury, and denies t hat petitioner's current disabi lities are the result of a vaccine

- related injury

.

Nevertheless, the parties agree to the joint stipulation, attached hereto. The undersigned finds said stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the term s set forth therein.

Damages awarded in that stipulation include:

A lump sum payment of $50,000.00 in the form of a check payable to petitioner. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa

- 15(a).

In the absence of a motion for review filed pursuant to RCFC, Appendix B, the clerk is directed to enter judgment in case 16

- 1197 V according to this decision and the attached stipulation. 2

IT IS SO ORDERED

.

s /Christian J. Moran

Christian J. Moran Special Master

2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each party filing a notice renouncing the right to seek review by a United States Court of Federal Claims judge.
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 4254 Engrossed in Senate (ES)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
117th CONGRESS
  2d Session
                                S. 4254

_______________________________________________________________________

                                 AN ACT

 
  To amend the Lobbying Disclosure Act of 1995 to clarify a provision 
     relating to certain contents of registrations under that Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Disclosing Foreign Influence in 
Lobbying Act''.

SEC. 2. CLARIFICATION OF CONTENTS OF REGISTRATION.

    Section 4(b) of the Lobbying Disclosure Act of 1995 (2 U.S.C. 
1603(b)) is amended--
            (1) in paragraph (6), by striking ``and'' at the end; and
            (2) in paragraph (7), by striking ``the offense.'' and 
        inserting the following: ``the offense; and
            ``(8) notwithstanding paragraph (4), the name and address 
        of each government of a foreign country (including any agency 
        or subdivision of a foreign government, such as a regional or 
        municipal unit of government) and foreign political party, 
        other than the client, that participates in the direction, 
        planning, supervision, or control of any lobbying activities of 
        the registrant.''.

            Passed the Senate September 29, 2022.

            Attest:

                                                             Secretary.
117th CONGRESS

  2d Session

                                S. 4254

_______________________________________________________________________

                                 AN ACT

  To amend the Lobbying Disclosure Act of 1995 to clarify a provision 
     relating to certain contents of registrations under that Act.
```